1-Bromopropane → HCID 53716832、化合物
反応式
[NH:1]1[C:7]2=[C:8]3[C:13](=[N:14][C:15]4=[CH:16][CH:17]=[CH:18][C:5](=[C:6]24)[O:4][CH2:3][C:2]1=[O:19])[CH2:12][CH2:11][CH2:10][CH2:9]3.[CH3:20][C:21](C)([O-])[CH3:22].[K+].BrCCC>O1CCCC1>[CH2:20]([N:1]1[C:7]2=[C:8]3[C:13](=[N:14][C:15]4=[CH:16][CH:17]=[CH:18][C:5](=[C:6]24)[O:4][CH2:3][C:2]1=[O:19])[CH2:12][CH2:11][CH2:10][CH2:9]3)[CH2:21][CH3:22]参加物
実験手順
To a suspension of 1,3,9,10,11,12-hexahydro-2H-quino[4,3,2-ef][1,4]benzoxazepin-2-one (4.94 g) in dry tetrahydrofuran (150 ml) was added potassium tert-butoxide (2.62 g). The mixture was stirred for 15 mins, 1-bromopropane (7.07 ml) was added, and the reaction mixture was refluxed overnight. The reaction mixture was concentrated, diluted with saturated potassium carbonate solution, and extracted with ethyl acetate. The organic extracts were dried over anhydrous magnesium sulfate, filtered, and the filtrate was concentrated. The residue was to adhered to silica, and flash chromatographed (30% ethyl acetate/hexane). The appropriate fractions were evaporated and the residue was triturated with diethyl ether to yield 4.39 g (76%) of 1,3,9,10,11,12-hexahydro-1-propyl-2H-quino[4,3,2-ef][1,4]benzoxazepin-2-one.
後処理
- temperaturethe reaction mixture was refluxed overnight
- concentrationThe reaction mixture was concentrated
- additiondiluted with saturated potassium carbonate solution
- extractionextracted with ethyl acetate
- dry with materialThe organic extracts were dried over anhydrous magnesium sulfate
- filtrationfiltered
- concentrationthe filtrate was concentrated
- customchromatographed (30% ethyl acetate/hexane)
- customThe appropriate fractions were evaporated
- customthe residue was triturated with diethyl ether
出典と根拠
- ORDレコード
- ord-d14a6c3c111346de93bb3b309bd91ff3
- 出典データセット
- uspto-grants-1992_05
- 特許番号
- US05112829
反応ノート
読み込み中…